IP Library Granted Patent US 12,385,014
Granted Patent B2
US 12,385,014 · App. 16/321,634 · Granted Aug 12, 2025

Baculovirus expression system

Inventors: Martine Cerutti (Saint Christol les Ales, FR); Sylvie Juliant (Saint Christol les Ales, FR); Sylvie Thery (Saint Martin de Valgalgues, FR)
Assignees: CENTRE NATIONAL DEL LA RECHERCH SCIENTIFIQUE (CNRS); INSTITUT NATIONAL DE LA RECHERCHE AGRONOMQIUE
C12N7/00C12N15/86C12N15/902C12N2710/14151
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,385,014
App. No.
16/321,634
Granted
Aug 12, 2025
Kind
B2
Abstract

The invention relates to a method for producing a recombinant baculovirus comprising n exogenous genes in an insect cell, by means of homologous recombination of a replication-deficient baculovirus genome and n transfer vectors, each comprising one of the n exogenous genes, n being an integer at least equal to 2.

Claims (17)

1. A process for preparing, in an insect cell, a recombinant baculovirus comprising n exogenous gene expression cassettes each to be expressed at a different locus, the process comprising introducing a replication-deficient recombinant baculovirus genome and n transfer vectors into an insect cell and thereby allowing multiple homologous recombination between:

a) a replication-deficient baculovirus genome in which n genes essential for viral replication are distributed in n different loci of the viral DNA and are all non-functional, wherein the n non-functional genes essential for viral replication are each adjacent to a different gene non-essential for viral replication; and

b) n transfer vectors each restoring the function of only one of the n non-functional genes essential for viral replication and each comprising:

i) a nucleotide sequence that restores the function of only one of the n non-functional genes essential for viral replication, and

ii) only one of the n exogenous gene expression cassettes, each of the n expression cassettes to be expressed at a different locus,

the set of nucleotide sequences i) of the n transfer vectors being able to restore replication of the replication-deficient baculovirus genome;

wherein all n being the same and being an integer at least equal to 2, and

wherein the replication-deficient baculovirus genome and the n transfer vectors are all present in the same insect cell simultaneously, prior to the multiple homologous recombination with all n transfer vectors.

2. The process according to claim 1 , wherein the genes essential for viral replication are selected from 1629 (ORF9), Pk1 (ORF10), lef-1 (ORF14), ORF34, lef-11 (ORF37), p47 (ORF40), lef8 (ORF50), DNAJ domain (ORF51), ORF53, vp1054 (ORF54), Lef-9 (ORF62), DNA Pol (ORF65), lef-3 (ORF67), ORF73, ORF75, ORF81, p95 (ORF83), vp39 (ORF89), lef-4 (ORF90), p33 (ORF92), helicase (ORF95), vp80 (ORF104), ORF106-107, odv-ec43 (ORF109), gp64/67 (ORF128), ORF132, ORF133, odv-ec27 (ORF144), ORF146, ie1 (ORF147) and lef-2 (ORF6).

3. The process according to claim 1 , wherein the gene non-essential for viral replication is selected from Ph (ORF 8), ORF11, ORF13, egt (ORF15), v-ubiquitin (ORF35), 39K (ORF36), ORF38, p43 (ORF39), lef-12 (ORF41), pcna (ORF49), ORF52, ORF55, Fp (ORF61), ORF63, gp37 (ORF64), ORF68, ORF72, ORF74, ORF82, cg30 (ORF88), ORF91, pif-4 (ORF96), he65 (ORF105), ORF108, ORF110, cathepsin (ORF127), p24 (ORF129), pp34 (ORF131), ORF134, ORF145, odv-e56 (ORF148) and ORF5.

4. The process according to claim 1 , wherein the n exogenous gene expression cassettes each recombine with a gene non-essential for viral replication adjacent to a non-functional gene essential for viral replication.

5. The process according to claim 1 , wherein the transfer vectors comprise, on either side of one of the n exogenous gene expression cassettes, flanking sequences homologous to the replication-deficient baculovirus genome.

6. The process according to claim 5 , wherein the flanking sequences have a length ranging from 10 bp to 10 kb.

7. The process according to claim 1 , wherein the insect cell is selected from the group consisting of: Sf9, Sf21, Tn5-b14, baculovirus AcMNPV-sensitive lepidopteran cell lines, and Sf21 lines.

8. The process according to claim 1 , wherein the replication-deficient baculovirus genome is obtained from a baculovirus genome selected among or derived from the group of the baculovirus genomes consisting of: BmNPV, AcMNPV, ApNPV, BsSNPV, CMNPV, EOSNPV, HaNPV, HzNPV, LdMNPV, MbMNPV, OpMNPV, SIMNPV, SeMNPV and TeNPV.

9. The process according to claim 1 , wherein n is an integer ranging from 2 to 30.

10. The process according to claim 1 , wherein the replication-deficient baculovirus genome is obtained from the baculovirus genome of AcMNPV.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2024
From: CERUTTI, MARTINE; JULIANT, SYLVIE; THERY, SYLVIE
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
Reel/Frame 067499/0885 →
CHANGE OF NAME Recorded Jun 15, 2021
From: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA)
To: INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Reel/Frame 056592/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2019
From: CERUTTI, MARTINE; THERY, SYLVIE
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
Reel/Frame 048455/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2019
From: JULIANT, SYLVIE
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
Reel/Frame 048455/0639 →
Priority Claims (1)
FR 1657611 · Aug 5, 2016 · national
Continuity (1)
Related Publication 20230063208A1 · Mar 2, 2023
References Cited (37)
US 9212374B2 · Roy · 2015 [cited by examiner]
US 20230063208A1 · Cerutti et al. · 2023 [cited by applicant]
WO 2001012829A2 · 2001 [cited by applicant]
WO WO0112829A2 · 2001 [cited by examiner]
WO 2010055292A2 · 2010 [cited by applicant]
WO 2013005194 · 2013 [cited by applicant]
WO 2018024998 · 2018 [cited by applicant]
Weyer U, Possee RD. A baculovirus dual expression vector derived from the Autographa californica nuclear polyhedrosis virus polyhedrin and p10 promoters: co-expression of two influenza virus genes in insect cells. J Gen… [cited by examiner]
St Angelo C, Smith GE, Summers MD, Krug RM. Two of the three influenza viral polymerase proteins expressed by using baculovirus vectors form a complex in insect cells. J Virol. Feb. 1987;61(2):361-5. doi: 10.1128/JVI.61… [cited by examiner]
Je et al. Generation of Baculovirus Expression Vector Using Defective Autographa californica Nuclear Polyhedrosis Virus Genome Maintained in [cited by examiner]
Van Oers MM. Opportunities and challenges for the baculovirus expression system. J Invertebr Pathol. Jul. 2011;107 Suppl:S3-15. (Year: 2011). [cited by examiner]
Gay et al., “Insertion of transposon Tn7 into the [cited by applicant]
Drocourt et al., “Chemical synthesis and biological activities of analogues of 2′,5′-oligoadenylates containing 8-substituted adenosine derivatives,” Nucleic Acids Research, 18(13):4439-4446 (1990). [cited by applicant]
Gentz et al., “Promoters Recognized by [cited by applicant]
Kwon et al, “Bipartite Modular Structure of Intrinsic, RNA Hairpin-independent Termination Signal for Phage RNA Polymerases” J Biol. Chem., 274(49):34940-34947 (1999). [cited by applicant]
Kanai et al., “Multiple large foreign protein expression by a single recombinant baculovirus: A system for production of multivalent vaccines,” Protein Expression and Purification, 91:77-84 (2013). [cited by applicant]
Possee et al., “Generation of Baculovirus Vectors for the High-Throughput Production of Proteins in Insect Cells,” Biotechnology and Bioengineering, 101(6):1115-1122 (2008). [cited by applicant]
Poul et al., “Design of cassette baculovirus vectors for the production of therapeutic antibodies in insect cells,” Immunotechnology, 1(3):189-196 (1995). [cited by applicant]
Vijayachandran et al., “Gene gymnastics,” Bioengineered, 4(5):279-287 (2013). [cited by applicant]
Pijlman et al., “Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells,” Journal of General Virology, 84(10):2669-2678 (2003). [cited by applicant]
Palmberger D, Wilson IB, Berger I, Grabherr R, Rendic D. SweetBac: a new approach for the production of mammalianised glycoproteins in insect cells. PLoS One. 2012;7(4):e34226. [cited by applicant]
Chang GD, Chen CJ, Lin CY, Chen HC, Chen H. Improvement of glycosylation in insect cells with mammalian glycosyltransferases. J Biotechnol. Apr. 10, 2003;102(1):61-71. [cited by applicant]
Possee RD, Hitchman RB, Richards KS, Mann SG, Siaterli E, Nixon CP, Irving H, Assenberg R, Alderton D, Owens RJ, King LA. Generation of baculovirus vectors for the high-throughput production of proteins in insect cells.… [cited by applicant]
Tan J, D'Agostaro AF, Bendiak B, Reck F, Sarkar M, Squire JA, Leong P, Schachter H. The human UDP-N-acetylglucosamine: alpha-6-D-mannoside-beta-1,2-N-acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA… [cited by applicant]
D'Agostaro G, Bendiak B, Tropak M. Cloning of cDNA encoding the membrane-bound form of bovine beta 1,4- galactosyltransferase. Eur J Biochem. Jul. 15, 1989;183(1):211-7. [cited by applicant]
Munster AK, Eckhardt M, Potvin B, Mühlenhoff M, Stanley P, Gerardy-Schahn R. Mammalian cytidine 5′-monophosphate N-acetylneuraminic acid synthetase: a nuclear protein with evolutionarily conserved structural motifs. Pro… [cited by applicant]
Lawrence SM, Huddleston KA, Pitts LR, Nguyen N, Lee YC, Vann WF, Coleman TA, Betenbaugh MJ. Cloning and expression of the human N-acetylneuraminic acid phosphate synthase gene with 2-keto-3-deoxy-D-glycero-D-galacto-non… [cited by applicant]
Kitagawa H, Paulson JC. Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem. Jan. 14, 1994;269(2):1394-401. [cited by applicant]
Grundmann U, Nerlich C, Rein T, Zettlmeissl G. Complete cDNA sequence encoding human beta-galactoside alpha-2,6-sialyltransferase. Nucleic Acids Res. Feb. 11, 1990;18(3):667. [cited by applicant]
Cieplik M, M, Klenk HD, Garten W. Identification and characterization of spodoptera frugiperda furin: a thermostable subtilisin-like endopeptidase. Biol Chem. Dec. 1998;379(12):1433-40.B23-B23. [cited by applicant]
Jarvis DL, Finn EE. Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells. Virology. Oct. 1, 1995;212(2):500-11. [cited by applicant]
Jarvis, DL et al, Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production, 75(13), 6223-6227, 200. [cited by applicant]
Ribeiro JP, Pau W, Pifferi C, Renaudet O, Varrot A, Mahal LK, Imberty A. Characterization of a high-affinity sialic acid-specific CBM40 from Clostridium perfringens and engineering of a divalent form. Biochem J. Jul. 15… [cited by applicant]
Noad R.J. et al. Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA, BMC Molecular Biology 2009, 10:87 doi:10.1186/1471-2199-10-87. [cited by applicant]
Kost, T.A. et al. Baculovirus as versatile vectors for protein expression in insect and mammalian cells, Nature Biotechnology vol. 23, No. 5, 567-575, 2005. [cited by applicant]
Cerutti M. et al. Lepidopteran cells, an alternative for the production of recombinant antibodies? mAbs 4:3 294-309, 2012. [cited by applicant]
Juliant S. et al. Engineering the Baculovirus Genome to Produce Galactosylated Antibodies in Lepidopteran Cells. Glycosylation Engineering of Biopharmaceuticals: Methods and Protocols, Methods in Molecular Biology, vol.… [cited by applicant]